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Objective- To compare the effectiveness of intratympanic Gentamicin with 
intratympanic Methylprednisolone with regards to vertigo control, tinnitus control, 
hearing and functional score improvement in the treatment of symptoms in patients 
with unilateral, intractable Meniere’s disease with non serviceable hearing 
Study design- Randomized prospective parallel group trial 
Setting- Tertiary care centre in south India 
Subjects and methods- Twenty patients with definite unilateral Meniere’s disease with 
average pure tone threshold more than 50 dB in the affected ear were enrolled 
between November 2016 and August 2018. Eleven patients were treated with 
intratympanic buffered Gentamicin (total of 4 injections, 40mg/ml, given on alternate 
days). Eleven patients were administered intratympanic Methylprednisolone (total of 4 
injections, 40mg/ml, given on alternate days). Pure tone audiogram, vertigo episodes, 
dizziness handicap inventory, tinnitus handicap inventory and functional scores were 
compared pre intervention and 3 months post intervention. 
Result- In the gentamicin group, of 11 patients, 7 (63.6%) were completely free of 
vertigo episodes at 3 month follow up. 3 of 11(27.2%) patients in the 
Methylprednisolone group were vertigo free at follow up. Gentamicin group had better 
post intervention Dizziness handicap Inventory scores (p=0.016) and Functional score 
(p=0.019). The change in hearing in both groups, post intervention was statistically 
insignificant (p=0.36)  
Conclusion- In patients with unilateral intractable Meniere’s disease with hearing loss 
>50dB and with no improvement on medical therapy, 4 doses of 40mg/ml intratympanic 
Gentamicin results in improvement in total DHI score, DHI functional score, DHI 
emotional score, Functional level scale, with better vertigo control rate and no 
significant worsening of hearing. 
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